Applied Spectral Imaging News
7 articles
growth-positive
Applied Spectral Imaging and KromaTiD Announce Strategic Commercial Partnership
Applied Spectral Imaging (ASI) has entered into a strategic commercial partnership with KromaTiD, Inc. ASI has been granted worldwide rights to market KromaTiDs proprietary Pinpoint FISH™ (PPF) probes and assay services. The partnership will benefit clinical laboratories, companies, and research institutions by enhancing their capabilities for comprehensive genomic structural measurements and improving diagnostic accuracy. ASIs imaging and analysis platform GenASIs will provide automation and advanced algorithms to realize the full potential of the PPF technology. KromaTiD will provide probes for common oncology and rare disease targets, as well as work with any researcher or clinical lab using ASIs imaging platform to develop high-resolution FISH assays. ASI is a global leader in biomedical imaging, while KromaTiD specializes in the discovery and characterization of structural genetic changes.
Partners
growth-positive
Applied Spectral Imaging (ASI) reveals advanced FISH solutions that deliver ultra-fast imaging analysis
Applied Spectral Imaging (ASI) has launched a new product update to meet the growing demands of pathology and cytogenetic laboratories. The update includes a novel imaging methodology and advanced hardware components to increase scanning speed for FISH imaging. ASIs diagnostic products offer ultra-fast sample scanning and computer-assisted analysis, resulting in easier FISH validation, shorter turnaround time, and higher reporting confidence. The update has been incorporated into ASIs Brightfield, Fluorescence, and Spectral imaging and analysis solutions. ASI is a global leader in biomedical imaging and analysis solutions, with a comprehensive product portfolio in digital diagnostics.
CustomersPartners
growth-positive
ARUP Laboratories and Applied Spectral Imaging Bring Medical Innovation to Pathology
ARUP Laboratories and Applied Spectral Imaging (ASI) have completed a multi-year collaboration to launch ASIs PathFusion, a solution that combines Whole Slide Imaging, Tissue FISH analysis, and digital tissue-matching of FISH with Brightfield samples. PathFusion automates the traditional process of FISH testing in pathology, providing higher diagnostic confidence and workflow efficiencies. The collaboration between ARUP and ASI represents ARUPs commitment to embracing modern technologies in clinical diagnostics. ASI will be holding a workshop featuring Dr. Salama to present data from a prospective study on the clinical impact and workflow efficiencies of PathFusion.
Partners
growth-positive
Applied Spectral Imaging Launches Two New Products for the Digital Pathology Market
Applied Spectral Imaging (ASI) has announced the launch of PathFusion and HiPath Pro, innovative Brightfield and FISH imaging & analysis solutions for pathology. These new products aim to bridge the gap between Brightfield pathology and FISH, providing accurate and validated analysis for higher diagnostic confidence. The PathFusion system combines Whole Slide Imaging, Tissue FISH applications, and digital tissue matching of FISH with H&E/IHC samples. HiPath Pro is a Brightfield imaging & analysis system for histopathology needs. Both products increase laboratory productivity and improve results standardization. ASI serves clinical laboratories, life science companies, and research institutions in over 50 countries.
PartnersCustomers
growth-positive
Danaher in talks to buy Israel's ASI for $30m
Danaher has signed a letter of intent for the acquisition of Applied Spectral Imaging, an Israeli company that sells computer imaging solutions for laboratories. The acquisition is valued at $30 million. Danaher, a US medical equipment firm, has a market cap of $62.3 billion and is focusing exclusively on scientific technology. This acquisition is part of Danahers growth strategy, as it has made over 400 acquisitions since 1984. Applied Spectral Imaging has raised over $26 million since its founding in 1993.
Acquisition
Applied Spectral Imaging Received South Korean Ministry of Food and Drug Safety (MFDS) Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67
Applied Spectral Imaging Announces the Launch of the GenASIs Automated Imaging Platforms for Genetic and Pathology Analysis
